A placebo is an inactive substance or sham intervention, made to be indistinguishable from the treatment under test, used as a comparator in a controlled study. The placebo effect is the measurable change in a participant’s condition that follows receiving a placebo — a change driven by expectation, the act of being treated and the natural course of a condition rather than by any active ingredient. This is a methodological explainer, not medical advice.
Why placebos are used
When people receive any intervention, several things change at once: the intervention itself, their expectation of benefit, the attention they receive, and the natural ebb and flow of their condition. To know whether a treatment works, researchers must separate its specific effect from all of these. A placebo group experiences everything except the active component, so the difference between the treatment group and the placebo group estimates the treatment’s true effect.
Blinding
Placebos work hand in hand with blinding. In a single-blind study participants do not know which group they are in; in a double-blind study neither participants nor the researchers assessing outcomes know. Blinding prevents conscious or unconscious bias from shaping how outcomes are reported or measured. For blinding to hold, the placebo must match the active treatment in appearance, taste and administration.
What the placebo effect is — and is not
The placebo effect is real and measurable, but it is often misunderstood. Part of what looks like a placebo response is in fact regression to the mean (people often enter studies when symptoms are at their worst, and naturally improve afterwards) and the natural history of the condition. Careful trial design with a no-treatment arm can help distinguish a genuine psychobiological placebo response from these statistical artefacts. The mirror image, the nocebo effect, describes adverse effects arising from negative expectation.
Ethical considerations
Using a placebo is appropriate when no proven effective treatment exists or when withholding active treatment poses no serious risk. Where an effective standard of care exists, trials usually compare a new treatment against that standard rather than against an inert placebo. The Declaration of Helsinki addresses these considerations, and ethics committees review them for every trial.
Placebos and the integrity of the record
A well-designed placebo-controlled trial, pre-registered and reported against the CONSORT standard, produces evidence that others can trust and reuse. The placebo is one of the clearest illustrations of how methodology protects against bias — a theme that runs through all rigorous research. See our companion articles on clinical trial phases and double-blind studies and bias control.
Frequently asked questions
What is a placebo?
A placebo is an inactive substance or sham procedure, designed to be indistinguishable from the real treatment, used as a comparison group so that a treatment’s specific effect can be isolated.
What is the placebo effect?
It is the change in a person’s condition after receiving a placebo, driven by expectation, the experience of being treated and the natural course of the condition rather than by any active ingredient.
Why are placebos important in clinical trials?
They allow researchers to separate a treatment’s genuine effect from expectation, attention and natural recovery. Combined with randomisation and blinding, they are central to a trial’s internal validity.
What is the nocebo effect?
The nocebo effect is the appearance of adverse symptoms arising from negative expectation rather than from an active cause — the mirror image of the placebo effect.
